Chemoinformaics analysis of DIHYDROCHELERYTHRINE
| Molecular Weight | 349.386 | nRot | 2 |
| Heavy Atom Molecular Weight | 330.234 | nRig | 25 |
| Exact Molecular Weight | 349.131 | nRing | 5 |
| Solubility: LogS | -7.066 | nHRing | 2 |
| Solubility: LogP | 4.971 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 52.0471 |
| nHD | 0 | BPOL | 27.7149 |
| QED | 0.693 |
| Synth | 2.603 |
| Natural Product Likeliness | 1.019 |
| NR-PPAR-gamma | 0.306 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.272 |
| Pgp-sub | 0.979 |
| HIA | 0.002 |
| CACO-2 | -4.973 |
| MDCK | 0.0000368 |
| BBB | 0.264 |
| PPB | 0.922249 |
| VDSS | 0.647 |
| FU | 0.0181665 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.975 |
| CYP2c19-sub | 0.626 |
| CYP2c9-inh | 0.751 |
| CYP2c9-sub | 0.923 |
| CYP2d6-inh | 0.976 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.877 |
| CYP3a4-sub | 0.437 |
| CL | 13.572 |
| T12 | 0.151 |
| hERG | 0.321 |
| Ames | 0.764 |
| ROA | 0.072 |
| SkinSen | 0.858 |
| Carcinogencity | 0.919 |
| EI | 0.033 |
| Respiratory | 0.897 |
| NR-Aromatase | 0.753 |
| Antiviral | Yes |
| Prediction | 0.806973 |